Life Science Leader Chief Editor Blog Header image
The Netherlands — More Than Just The New Home Of The EMA
What sets the Netherlands biopharma sector apart from the rest of the world? That’s what Chief Editor Rob Wright hoped to find out as he began his press tour of the country’s biopharma industry. Continue Reading..
Are Genetically Modified Organisms (GMO) A Blessing Or A Curse?
A question about GMOs submitted to our editorial board leads us to look more closely into this issue and how it affects the pharma industry. Continue Reading..
Why A Biopharma Executive Founded A Game-Changing Conference
Amir Kalali, M.D., former global head of Quintiles (now IQVIA) neuroscience center of excellence, provides insight on why he decided to found an educational conference, The CNS Summit, while still working as a biopharmaceutical industry executive. Continue Reading..
Is It Possible For A Biopharmaceutical Executive To Transcend Their Industry?
What current biopharma leaders have the potential to “transcend” beyond this industry? Chief Editor Rob Wright gives his top three choices. Continue Reading..
The Drug Pricing Dilemma, Pfizer, And President Trump
An op-ed regarding Pfizer’s drug-pricing actions, President Trump, and the potential impact on the biopharmaceutical industry’s image. Continue Reading..
At The End Of The Day — And Other Phrases That Could Be Used Less
A review of buzzwords and phrases that should be used less in the world of business. Continue Reading..